神経修復および再生の世界市場：洞察、競合情勢、市場予測：2030年

世界の神経修復および再生の市場規模は、2023年に64億9,747万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に9.31％のCAGRで拡大すると予測されています。神経修復および再生製品に対する需要の増加は、神経損傷の発生率の増加、糖尿病や高血圧などの生活習慣病の有病率の上昇などが主な要因です。さらに、神経修復製品ポートフォリオにおける技術的進歩や、最近の高い製品承認なども、神経修復および再生の世界市場成長に寄与する要因の一つです。したがって、上記の要因は、今後数年間における神経修復および再生市場の全体的な市場成長を促進すると予想されます。

現在、神経修復および再生市場は、糖尿病や高血圧などの生活習慣病が蔓延していることから、勢いを増しています。例えば、糖尿病は末梢神経ニューロパチーの発症につながる可能性のある主要な危険因子の一つと考えられており、感覚神経、運動神経、自律神経に軽度から重度の損傷を与え、さらに足のしびれ、ピリピリ感、灼熱感、片側のバンドや痛み、体幹や骨盤のしびれや脱力感などの症状を引き起こす可能性があります。神経栄養因子のレベル低下、受容体の発現低下、細胞シグナル経路の変化、細胞接着分子の異常発現などにより、糖尿病患者のほとんどで神経再生に障害が見られます。したがって、糖尿病の増加は、神経の修復と再生の有病率を増加させる可能性があります。神経調節装置のような機器は、糖尿病患者の神経修復および再生の管理または治療に使用され、それによって市場での需要が増加しています。このように、糖尿病は神経修復および再生製品の市場成長の潜在的要因として作用する可能性があります。

当レポートでは、世界の神経修復および再生市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 神経修復および再生市場レポートのイントロダクション

第2章 神経修復および再生市場のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本
• 中国

第4章 神経修復および再生市場の主な要因分析

• 神経修復および再生市場の促進要因
• 神経修復および再生市場の抑制要因と課題
• 神経修復および再生市場の機会

第5章 神経修復および再生市場におけるポーターのファイブフォース分析

第6章 神経修復および再生市場に対するCOVID-19の影響分析

第7章 神経修復および再生市場の概要

• 製品タイプ別
• エンドユーザー別
• 地域別

第8章 神経修復および再生の世界企業シェア分析-主要3～5社

第9章 神経修復および再生の企業と製品プロファイル

• Medtronic
• Boston Scientific Corporation
• AxoGen Inc.
• Baxter International
• Checkpoint Surgical, Inc.
• Integra Lifesciences Corporation
• Polyganics B.V.
• Orthomed S.A.S
• Salumedica, LLC
• Alafair Biosciences, Inc.
• Neurometrix, Inc.
• TOYOBO CO., LTD
• LivaNova PLC
• Synapse Biomedical, Inc.
• Abbott
• Keri Medical
• Nevro Corp.
• Collagen matrix, Inc.
• Aleva Neurotherapeutics SA
• Orthocell, Ltd.

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Nerve Repair and Regeneration market in Global (2021-2030)
• Table 4: Nerve Repair and Regeneration market in Global by Product Type (2021-2030)
• Table 5: Nerve Repair and Regeneration market in Global by End User (2021-2030)
• Table 6: Nerve Repair and Regeneration market in Global by Geography (2021-2030)
• Table 7: Nerve Repair and Regeneration market in North America (2021-2030)
• Table 8: Nerve Repair and Regeneration market in North America by Country (2021-2030)
• Table 9: Nerve Repair and Regeneration market in the US (2021-2030)
• Table 10: Nerve Repair and Regeneration market in Canada (2021-2030)
• Table 11: Nerve Repair and Regeneration market in Mexico (2021-2030)
• Table 12: Nerve Repair and Regeneration market in Europe (2021-2030)
• Table 13: Nerve Repair and Regeneration market in Europe by Country (2021-2030)
• Table 14: Nerve Repair and Regeneration market in France (2021-2030)
• Table 15: Nerve Repair and Regeneration market in Germany (2021-2030)
• Table 16: Nerve Repair and Regeneration market in the United Kingdom (2021-2030)
• Table 17: Nerve Repair and Regeneration market in Italy (2021-2030)
• Table 18: Nerve Repair and Regeneration market in Spain (2021-2030)
• Table 19: Nerve Repair and Regeneration market in Russia (2021-2030)
• Table 20: Nerve Repair and Regeneration market in Rest of Europe (2021-2030)
• Table 21: Nerve Repair and Regeneration market in APAC (2021-2030)
• Table 22: Nerve Repair and Regeneration market in APAC by Country (2021-2030)
• Table 23: Nerve Repair and Regeneration market in China (2021-2030)
• Table 24: Nerve Repair and Regeneration market in Japan (2021-2030)
• Table 25: Nerve Repair and Regeneration market in India (2021-2030)
• Table 26: Nerve Repair and Regeneration market in Australia (2021-2030)
• Table 27: Nerve Repair and Regeneration market in South Korea (2021-2030)
• Table 28: Nerve Repair and Regeneration market in Rest of APAC (2021-2030)
• Table 29: Nerve Repair and Regeneration market in Rest of World (2021-2030)
• Table 30: Nerve Repair and Regeneration market in RoW by Region (2021-2030)
• Table 31: Nerve Repair and Regeneration market in Middle East (2021-2030)
• Table 32: Nerve Repair and Regeneration market in Africa (2021-2030)
• Table 33: Nerve Repair and Regeneration market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Nerve Repair and Regeneration market in Global (2021-2030)
• Figure 4: Nerve Repair and Regeneration market in Global by Product Type (2021-2030)
• Figure 5: Nerve Repair and Regeneration market in Global by End User (2021-2030)
• Figure 6: Nerve Repair and Regeneration market in Global by Geography (2021-2030)
• Figure 7: Nerve Repair and Regeneration market in North America (2021-2030)
• Figure 8: Nerve Repair and Regeneration market in North America by Country (2021-2030)
• Figure 9: Nerve Repair and Regeneration market in the US (2021-2030)
• Figure 10: Nerve Repair and Regeneration market in Canada (2021-2030)
• Figure 11: Nerve Repair and Regeneration market in Mexico (2021-2030)
• Figure 12: Nerve Repair and Regeneration market in Europe (2021-2030)
• Figure 13: Nerve Repair and Regeneration market in Europe by Country (2021-2030)
• Figure 14: Nerve Repair and Regeneration market in France (2021-2030)
• Figure 15: Nerve Repair and Regeneration market in Germany (2021-2030)
• Figure 16: Nerve Repair and Regeneration market in the United Kingdom (2021-2030)
• Figure 17: Nerve Repair and Regeneration market in Italy (2021-2030)
• Figure 18: Nerve Repair and Regeneration market in Spain (2021-2030)
• Figure 19: Nerve Repair and Regeneration market in Russia (2021-2030)
• Figure 20: Nerve Repair and Regeneration market in Rest of Europe (2021-2030)
• Figure 21: Nerve Repair and Regeneration market in APAC (2021-2030)
• Figure 22: Nerve Repair and Regeneration market in APAC by Country (2021-2030)
• Figure 23: Nerve Repair and Regeneration market in China (2021-2030)
• Figure 24: Nerve Repair and Regeneration market in Japan (2021-2030)
• Figure 25: Nerve Repair and Regeneration market in India (2021-2030)
• Figure 26: Nerve Repair and Regeneration market in Australia (2021-2030)
• Figure 27: Nerve Repair and Regeneration market in South Korea (2021-2030)
• Figure 28: Nerve Repair and Regeneration market in Rest of APAC (2021-2030)
• Figure 29: Nerve Repair and Regeneration market in Rest of World (2021-2030)
• Figure 30: Nerve Repair and Regeneration market in RoW by Region (2021-2030)
• Figure 31: Nerve Repair and Regeneration market in Middle East (2021-2030)
• Figure 32: Nerve Repair and Regeneration market in Africa (2021-2030)
• Figure 33: Nerve Repair and Regeneration market in South America (2021-2030)
• Figure 34: Market Drivers
• Figure 35: Market Barriers
• Figure 36: Marker Opportunities
• Figure 37: PORTER'S Five Force Analysis

Nerve Repair And Regeneration Market By Product Type (Biomaterials [Nerve Connectors/Conduits, Nerve Protectors, Nerve Wraps, And Nerve Graft {Autografts, Allografts, And Xenografts}] And Neuromodulation Devices [External Neuromodulation Devices {Transcutaneous Electrical Nerve Stimulation Devices And Transcranial Magnetic Stimulation Devices} And Internal Neuromodulation Devices {Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, And Others Devices}]), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to expand at a constant CAGR forecast till 2030 owing to the growing incidence of nerve injuries and increasing prevalence of lifestyle and chronic disorders

The global nerve repair and regeneration market was valued at USD 6,497.47 million in 2023, growing at a CAGR of 9.31% during the forecast period from 2024 to 2030. The increase in demand for nerve repair and regeneration products is predominantly attributed to the increasing incidence of nerve injuries, rising prevalence of lifestyle disorders such as diabetes and hypertension, and others. Moreover, technological advancements in the nerve repair product portfolio and high product approvals in recent times, among others are also some of the factors contributing to the global market growth for nerve repair and regeneration. Therefore, the above mentioned factors are expected to propel the overall market growth of the nerve repair and regeneration market in the forthcoming years.

Nerve Repair And Regeneration Market Dynamics:

The market for nerve repair and regeneration is gaining momentum at present due to the growing prevalence of lifestyle-associated disorders such as diabetes and hypertension. For instance, diabetes is considered as one of the major risk factors that may lead to the development of peripheral nerve neuropathy and can lead to mild to severe forms of damage to the sensory, motor, and autonomic nerves further causing symptoms such as numb, tingling, or burning feet, one-sided bands or pain, and numbness and weakness on the trunk or pelvis. According to the statistics published by the International Diabetes Federation (IDF) Diabetes Atlas 2019 Ninth Edition, there were approximately 463 million adults in the age group 20-79 years were living with diabetes in 2019. Moreover, as per the tenth edition of the source, nearly 537 million adults were living with diabetes in the year 2023. The source further mentioned the numbers are expected to rise to 700 million by 2045. Disturbed nerve regeneration is seen in mostly diabetic patient due to decreased levels of neurotrophic factors, or due to decreased expression of their receptors, or due to altered cellular signal pathways and/or abnormal expression of cell adhesion molecules in a diabetic patient. Thus, increasing diabetes may increase the prevalence of nerve repair and regeneration. The devices such as neuromodulation devices are used for management or treatment of nerve repair and regeneration in a diabetic patient, thereby increasing its demand in the market. Thus, diabetes may act as potential factor for the market growth of nerve repair and regeneration products.

Furthermore, rising nerve injury cases across the globe is also a key factor responsible for the increased demand for nerve repair and regeneration products, thereby fuelling the global nerve repair and regeneration market. According to the National Institute of Neurological Disorders and Stroke (NINDS, 2022), in the United States, diseases of the peripheral nerve tend to affect approximately 20 million people, yearly.

Additionally, rising cases of traumatic injuries due to road accidents, occupational accidents, falls, among others could lead to peripheral nerve injuries, thereby raising the demand for the nerve repair and regeneration products. For instance, according to the International Labour Organization (ILO) 2022 data, worldwide, there are approximately 340 million occupational accidents annually. The accidents may damage the nerves of a patient, thereby increasing the need of nerve repair and regenerative products in the market.

Hence, all the above-mentioned factors are expected to bolster the global market for nerve repair and regeneration products.

However, the high cost associated with nerve repair and regeneration products and the availability of alternative treatment methods are likely to hinder the nerve repair and regeneration market growth in the forthcoming years.

The ongoing COVID-19 pandemic has negatively impacted the market for nerve repair and regeneration. The demand for nerve repair and regeneration products in the market had decreased due to the temporary suspension of numerous elective procedures and outpatient visits as the healthcare system guidelines worldwide temporarily focused all their efforts on the management of COVID-19 patient load during the lockdown period. Furthermore, with the disruption of raw materials, supply chain, cross border trades, man power and resources, the key players halted their manufacturing units, thereby decreasing the number of devices in the market. However, owing to the approval & administration of numerous COVID-19 vaccines across the globe and with the upturn of all the resources, there is a significant improvement in the resumption of activities across various domains, including healthcare services, thereby paving the way for a sound period of recovery for the nerve and regeneration market. Thus, the overall market of nerve repair and regeneration products is anticipated to grow at a steady rate in the forecast period.

Nerve Repair And Regeneration Market Segment Analysis:

Nerve Repair And Regeneration Market by Product Type (Biomaterials [Nerve Connectors/Conduits, Nerve Protectors, Nerve Wraps, and Nerve Graft {Autografts, Allografts, and Xenografts}] and Neuromodulation Devices [External Neuromodulation Devices {Transcutaneous Electrical Nerve Stimulation Devices and Transcranial Magnetic Stimulation Devices} and Internal Neuromodulation Devices {Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, and Others Devices}]), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the nerve repair and regeneration product segment, the nerve protector's sub-segment in the biomaterials category is estimated to grow at a healthy CAGR of 10.57% during the forecast period from 2024-2030.

This is owing to the advantages associated with nerve protectors. For instance, nerve protectors provide a non-constricting encasement for injured peripheral nerves for protection of the neural environment. They are designed to be an interface between the nerve and the surrounding tissue. Moreover, nerve protectors are an essential component in nerve repair and regeneration as they provide protection to the nerve from the surrounding soft tissue attachments and help in nerve reconstruction.

Furthermore, nerve protectors preserve the native architecture of the extracellular matrix around the targeted nerve, protect from the formation of scar tissue, and prevent nerve compression.

Moreover, with the increase in product launch, approvals, and other regulatory steps, in the local market, which in-turn are also anticipated to increase the overall market growth of the nerve protectors. For instance, Axogen Inc., a developer of surgical solutions, including human tissue grafts, received the product approval for their nerve protector in October 2022 by the European Union and was awarded the CE mark. These approvals by regulatory bodies further act as growth opportunities for the market as they help establish product credibility among end-users.

Therefore, owing to the advantages associated with nerve protectors in nerve repair and regeneration and with the increase in number of regulatory approvals, there will be an increase in the demand for nerve protectors, which in turn is estimated to drive the nerve repair and regeneration market growth.

North America is expected to dominate the overall Nerve Repair And Regeneration Market:

Among all the regions, North America is expected to hold a major share of 31.55% in the overall nerve repair and regeneration market in the year 2023 and is expected to hold its position during the forecasted period from 2024-2030. This domination is due to the rise in the number of neurological conditions, the presence of leading nerve repair and regeneration companies, strong R&D, and regulatory guidelines, among others.

For instance, according to the American Association of Electro-diagnostic Medicine, of all patients admitted to Level I trauma centers yearly, roughly 2-3% have peripheral nerve injuries. The increasing number of peripheral nerve injuries in the region will increase the demand of nerve repair and regeneration products as these products are used for the treatment and management of the disorder. Moreover, rising trauma injury cases in the region are likely to boost the demand for nerve repair and regeneration products. According to the U.S. Bureau of Labor Statistics 2022, there were 2.7 million nonfatal workplace injuries in the region in the year 2020. The surging number of injuries may injure the nervous system thereby increasing the risk of nerve damage and degeneration. The nerve repair and regenerative products may aid in the treatment of nerve damage. Thus, the increasing number of injuries may increase the demand of nerve repair and regenerative devices, thereby propelling the overall market.

In addition, the rise in the number of chronic pain associated with nerve and neurology-associated disorders is also expected to raise the demand for nerve repair and regeneration products. According to the Centres for Disease and Prevention 2020 data, the overall prevalence of chronic pain in the US was 20.4%, in the year 2020.

Henceforth, the rise in neurological disorders and nerve injury cases in the country will boost the market for nerve repair and regeneration products in the forecast period, 2022 - 2028.

Moreover, the presence of well-established nerve repair and regeneration players such as Boston Scientific Incorporation, Medtronic plc., Stryker Corporation, and Nevro Corporation, among others in the region, is the predominant factor contributing to the nerve repair and regeneration market.

Additionally, the recent approval of nerve repair devices in the region will further augment the market. For instance, in September 2020, Axonics, had received Health Canada approval for the next generation implantable neurostimulator, Axonics r-SNM® System. It is currently the only rechargeable sacral neuromodulation (SNM) system available in Canada.

Thus, all the above-stated factors are expected to further bolster the market for nerve repair and regeneration market in the North American region.

Furthermore, Europe holds the second-largest market for nerve repair and regeneration products. This owing to recent launches and approvals pertaining to nerve repair and regeneration, rise in nerve injuries, rising acquisitions and mergers, and increasing lifestyle-related disorders, among others. For instance, Cook Biotech had received the CE Mark approval for Axoguard Nerve Connector and Axoguard Nerve Protector in March 2020. Additionally, the surge in the number of various diseases such as rheumatoid arteritis, osteoporosis, diabetes, lymphoma, among others in the region will spur the demand for nerve repair products.

Hence all the factors mentioned above will lead to the nerve repair and regeneration market in the region.

Nerve Repair And Regeneration Market Key Players:

Some of the key market players operating in the nerve repair and regeneration market include Medtronic, Boston Scientific Corporation, AxoGen Inc., Baxter International, Checkpoint Surgical, Inc., Integra Lifesciences Corporation, Polyganics B.V., Orthomed S.A.S, Salumedica, LLC, Alafair Biosciences, Inc., Neurometrix, Inc., TOYOBO CO., LTD, LivaNova PLC, Synapse Biomedical, Inc., Abbott, Keri Medical, Nevro Corp., Collagen matrix, Inc., Aleva Neurotherapeutics SA, Orthocell, Ltd., among others.

Recent Developmental Activities in the Nerve Repair And Regeneration Market:

In July 2022, Pulsetto, Healthtech startup, has launched a neuromodulation device that stimulates the vagus nerve. Stimulating this nerve with electric impulses activates the parasympathetic nervous system, allowing the body to rest and relax. This device can be used for nerve regeneration.

In January 2022, Checkpoint Surgical, Inc., the leader in intraoperative nerve repair stimulation technology, announced it has enrolled the first patient in its multi-center clinical study of the company's breakthrough nerve regeneration technology, Checkpoint BEST (Brief Electrical Stimulation Therapy) system.

In March 2022, Integra LifeSciences, introduced NeuraGen 3D Nerve Guide Matrix, a resorbable implant for the repair of peripheral nerve discontinuities. This product is developed to make an optimized environment, which would enable a more complete functional recovery following mid-gap nerve repair when compared to hollow nerve conduits alone.

In August 2022, Checkpoint Surgical Inc., a privately held medical device company committed to providing surgeons with user-friendly, cost-effective devices to protect and repair nerves intraoperatively, acquired Monarch Bio implants, the developer and manufacturer of Neuroshield Chitosan Nerve Wrap.

Key Takeaways from the Nerve Repair And Regeneration Market Report Study

• Market size analysis for current nerve repair and regeneration market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the nerve repair and regeneration market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global nerve repair and regeneration market.
• Various opportunities available for the other competitor in the nerve repair and regeneration market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current nerve repair and regeneration market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for nerve repair and regeneration market growth in the coming future?

Target Audience who can be benefited from the Nerve Repair And Regeneration Market Report Study

• Nerve Repair and Regeneration providers
• Research organizations and consulting companies
• Nerve Repair and Regeneration-related organization, association, forum, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders in Nerve Repair and Regeneration
• Various End-users want to know more about the nerve repair and regeneration market and the latest technological developments in the nerve repair and regeneration market.

Frequently Asked Questions for the Nerve Repair And Regeneration Market:

1. What are Nerve Repair and Regeneration?

Nerve repair is a complex biological process that starts immediately after a nerve injury occurs. Nerve repair comprises of approximation of the ends of an injured nerve via the direct form of nerve repair, nerve grafts, or nerve tubes. Nerve regeneration is the regrowth of the nervous tissues via the generation of new neurons, axons, synapses, and glial cells. The products mainly for nerve repair and regeneration include nerve conduits, nerve protectors, nerve caps in biomaterial, and neuromodulation devices.

2. What is the market for Global Nerve Repair and Regeneration?

The global Nerve Repair and Regeneration Market was valued at USD 6,497.47 million in 2023, growing at a CAGR of 9.31% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Nerve Repair and Regeneration?

The major factors driving the demand for nerve repair and regeneration are the rising cases of nerve injuries, increase in the prevalence of lifestyle disorders such as diabetes, hypertension, and others, increase in technological advancement in the product arena along with increased R&D and product approvals.

4. What are the key players operating in Global Nerve Repair and Regeneration?

Some of the key market players operating in the Nerve Repair and Regeneration market include Medtronic, Boston Scientific Corporation, AxoGen Inc., Baxter International, Checkpoint Surgical, Inc., Integra Lifesciences Corporation, Polyganics B.V., Orthomed S.A.S, Salumedica, LLC, Alafair Biosciences, Inc., Neurometrix, Inc., TOYOBO CO., LTD, LivaNova PLC, Synapse Biomedical, Inc., Abbott, Keri Medical, Nevro Corp., Collagen matrix, Inc., Aleva Neurotherapeutics SA, Orthocell, Ltd., among others.

5. Which region has the highest share in the Nerve Repair and Regeneration market?

Among all the regions, North America is expected to occupy a major share in the overall nerve repair and regeneration market in the year 2023 and is expected to hold its position during the forecasted period. This domination is due to the rise in the number of neurological conditions, the presence of leading nerve repair and regeneration companies, strong R&D, and regulatory guidelines, among others.

Table of Contents

1. Nerve Repair and Regeneration Market Report Introduction

2. Nerve Repair and Regeneration Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Nerve Repair and Regeneration Market Key factors analysis

• 4.1. Nerve Repair and Regeneration Market Drivers
  • 4.1.1. Growing incidence of nerve injuries
  • 4.1.2. Increasing prevalence of lifestyle disorders
  • 4.1.3. Technological advancement in nerve repair
• 4.2. Nerve Repair and Regeneration Market Restraints and Challenges
  • 4.2.1. Availability of alternative therapies
  • 4.2.2. High cost associated with Nerve Repair and Regeneration products
• 4.3. Nerve Repair and Regeneration Market Opportunities
  • 4.3.1. Product improvement in terms of safety
  • 4.3.2. Targeting emerging markets for product launches

5. Nerve Repair and Regeneration Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Nerve Repair and Regeneration Market

7. Nerve Repair and Regeneration Market layout

• 7.1. By Product Type
  • 7.1.1. Biomaterials
    • 7.1.1.1. Nerve Connectors/Conduits
    • 7.1.1.2. Nerve Protectors
    • 7.1.1.3. Nerve Wraps
    • 7.1.1.4. Nerve Grafts
    • 7.1.1.4.1. Autografts
    • 7.1.1.4.2. Allografts
    • 7.1.1.4.3. Xenografts
  • 7.1.2. Neuromodulation Devices
    • 7.1.2.1. External Neuromodulation Devices
    • 7.1.2.1.1. Transcutaneous Electrical Nerve Stimulation Devices
    • 7.1.2.1.2. Transcranial Magnetic Stimulation Devices
    • 7.1.2.2. Internal Neuromodulation Devices
    • 7.1.2.2.1. Spinal Cord Stimulation Devices
    • 7.1.2.2.2. Deep Brain Stimulation Devices
    • 7.1.2.2.3. Sacral Nerve Stimulation Devices
    • 7.1.2.2.3. Vagus Nerve Stimulation Devices
    • 7.1.2.2.4. Others
• 7.2. End-User
  • 7.2.1. Hospitals
  • 7.2.2. Ambulatory Surgical Centres
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.1.2. Canada Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.1.3. Mexico Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.2.2. Germany Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.2.3. United Kingdom Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.2.4. Italy Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.2.5. Spain Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.2.6. Russia Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.2.7. Rest of Europe Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.3.2. Japan Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.3.3. India Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.3.4. Australia Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.3.5. South Korea Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.3.6. Rest of Asia Pacific Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.4.2. Africa Nerve Repair and Regeneration Market Size in USD Million (2021-2030)
    • 7.3.4.3. South America Nerve Repair and Regeneration Market Size in USD Million (2021-2030)

8. Nerve Repair and Regeneration Global Company Share Analysis - Key 3-5 Companies

9. Nerve Repair and Regeneration Company and Product Profiles

• 9.1. Medtronic
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Boston Scientific Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. AxoGen Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Baxter International
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Checkpoint Surgical, Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Integra Lifesciences Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Polyganics B.V.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Orthomed S.A.S
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Salumedica, LLC
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Alafair Biosciences, Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Neurometrix, Inc.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. TOYOBO CO., LTD
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. LivaNova PLC
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Synapse Biomedical, Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Abbott
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Keri Medical
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Nevro Corp.
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Collagen matrix, Inc.
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. Aleva Neurotherapeutics SA
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Orthocell, Ltd.
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us